Disease-modifying Therapy Discontinuation and Outcomes of Older People with Multiple Sclerosis (MS) at a Large Academic MS Center in Toronto, Canada (S3.005)
To describe the clinical characteristics of older people with multiple sclerosis (pwMS), proportion and reasons for older pwMS to discontinue disease-modifying therapy (DMT), and rates of clinical and MRI disease activity after discontinuation.
Authors
- Jiwon Oh (ORCID: https://orcid.org/0000-0001-5519-6088)
- Chia‐Chen Tsai (ORCID: https://orcid.org/0000-0001-6907-1104)
- James Marriott (ORCID: https://orcid.org/0000-0001-5491-0569)
- Raphaël Schneider (ORCID: https://orcid.org/0000-0003-1776-2418)
- Fasna Raufdeen
Institutions
- St. Michael's Hospital (CA)
- University of British Columbia (CA)
- University of Toronto (CA)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210851
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00